Advertisement

Topics

FluGen Company Profile

00:48 EDT 26th September 2018 | BioPortfolio

FluGen is an emerging leader in the fight to boost effectiveness of influenza vaccines and other infectious disease products. The company has differentiating technologies that enable it to create value and compete in the large, rapidly growing influenza vaccine market. FluGen is actively advancing a valuable product pipeline that provides the company with unique competitive advantages that address significant unmet customer needs. These products include its REDEE FLU™ single replication influenza vaccine and its novel, vaccine-loaded intradermal delivery technology. For more information about FluGen, please visit our web site at www.flugen.com


News Articles [8 Associated News Articles listed on BioPortfolio]

FluGen doses first subject in new study of M2SR for influenza

FluGen has dosed the first subject in a new clinical trial evaluating the M2SR vaccine to treat subjects with an...Read More... The post FluGen doses first subject in new study of M2SR for influenza a...

NIH Using Vaccines from Madison Startup FluGen in New Clinical Trial

Researchers are testing a flu vaccine developed by FluGen, a Madison, WI-based startup, to determine whether it can protect recipients against strains of the virus that vary from the predominant strai...

FluGen to Study Versatility of Its Universal Flu Vaccine Candidate

The U.S. is coming off the worst influenza season in nearly a decade, highlighting the potential benefit of a universal flu vaccine that could protect against multiple strains of the disease. One comp...

FluGen Begins Enrollment of Clinical Trial of Novel Investigational Influenza Vaccine Against Multi-Season Mismatched Strains

—Investigational vaccine designed to generate broad and durable immune protection over multiple influenza seasons— —Subjects challenged with influenza virus genetic...

FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge

Last week, the Bill and Melinda Gates Foundation announced that it plans to provide researchers with up to $12 million in funding as part of a new initiative to support the development of a universal ...

FluGen Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09032018] Prices from USD $250

SummaryFluGen Inc FluGen is a healthcare services provider that offers vaccine and therapies. The company discovers, develops and commercializes new methods for the prevention and treatment of influen...

FluGen Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17042018] Prices from USD $250

SummaryFluGen Inc FluGen is a developer of influenza vaccines and therapies. The company discovers, develops and commercializes new methods for the prevention and treatment of influenza infections. It...

FluGen Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11072018] Prices from USD $250

SummaryFluGen Inc FluGen is a developer of influenza vaccines and therapies. The company discovers, develops and commercializes new methods for the prevention and treatment of influenza infections. It...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Safety and Immunogenicity Study of an Influenza Vaccination Strategy Including an H3N2 M2SR Prime Followed by a Seasonal Quadrivalent Inactivated Vaccine Boost in a Pediatric Population 9-17 Years Old

This is a Phase I double-blind, randomized, placebo-controlled study in 50 healthy adolescents and children, 9-17 years of age, inclusive, who are in good health and meet all eligibility c...

Companies [3 Associated Companies listed on BioPortfolio]

FluGen

FluGen is an emerging leader in the fight to boost effectiveness of influenza vaccines and other infectious disease products. The company has differentiating technologies that ena...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented ...

FluGen Inc.

FluGen, Inc. is a clinical stage vaccine company focused on improving the breadth and effectiveness of influenza vaccines. The Company’s technology comes from the laboratory ...

More Information about "FluGen" on BioPortfolio

We have published hundreds of FluGen news stories on BioPortfolio along with dozens of FluGen Clinical Trials and PubMed Articles about FluGen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FluGen Companies in our database. You can also find out about relevant FluGen Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Swine Flu - H1N1 influenza - H7N9
Swine flu is the common name given to a relatively new strain of influenza (flu) that caused a flu pandemic in 2009-2010. It is also referred to as H1N1 influenza (because it is the H1N1 strain of virus). The H1N1 flu virus will be one of the main vi...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Influenza
Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...


Corporate Database Quicklinks



Searches Linking to this Company Record